These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25159539)

  • 1. Glucose metabolism measured by positron emission tomography is reduced in patients with white matter presumably ischemic lesions.
    Li J; Hu W
    Med Sci Monit; 2014 Aug; 20():1525-30. PubMed ID: 25159539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between white matter lesions and the cerebral glucose metabolism in patients with cognitive impairment.
    No HJ; Yi HA; Won KS; Chang HW; Kim HW
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(3):160-166. PubMed ID: 31053556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
    Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
    Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative glucose metabolic rate higher in white matter in patients with schizophrenia.
    Buchsbaum MS; Buchsbaum BR; Hazlett EA; Haznedar MM; Newmark R; Tang CY; Hof PR
    Am J Psychiatry; 2007 Jul; 164(7):1072-81. PubMed ID: 17606659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White Matter Imaging Correlates of Early Cognitive Impairment Detected by the Montreal Cognitive Assessment After Transient Ischemic Attack and Minor Stroke.
    Zamboni G; Griffanti L; Jenkinson M; Mazzucco S; Li L; Küker W; Pendlebury ST; Rothwell PM;
    Stroke; 2017 Jun; 48(6):1539-1547. PubMed ID: 28487328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Cilostazol Administration in Alzheimer's Disease Patients with White Matter Lesions: A Positron-Emission Tomography Study.
    Lee JY; Lee H; Yoo HB; Choi JS; Jung HY; Yoon EJ; Kim H; Jung YH; Lee HY; Kim YK
    Neurotherapeutics; 2019 Apr; 16(2):394-403. PubMed ID: 30761509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.
    Roelcke U; Kappos L; Lechner-Scott J; Brunnschweiler H; Huber S; Ammann W; Plohmann A; Dellas S; Maguire RP; Missimer J; Radü EW; Steck A; Leenders KL
    Neurology; 1997 Jun; 48(6):1566-71. PubMed ID: 9191767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced white matter reorganization and activated brain glucose metabolism by enriched environment following ischemic stroke: Micro PET/CT and MRI study.
    Li M; Zhao Y; Zhan Y; Yang L; Feng X; Lu Y; Lei J; Zhao T; Wang L; Zhao H
    Neuropharmacology; 2020 Oct; 176():108202. PubMed ID: 32615189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of regional white matter lesions on cognitive function in subcortical vascular cognitive impairment.
    Ai Q; Pu YH; Sy C; Liu LP; Gao PY
    Neurol Res; 2014 May; 36(5):434-43. PubMed ID: 24641691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical image analysis of cerebral glucose metabolism in patients with cognitive impairment following diffuse traumatic brain injury.
    Kato T; Nakayama N; Yasokawa Y; Okumura A; Shinoda J; Iwama T
    J Neurotrauma; 2007 Jun; 24(6):919-26. PubMed ID: 17600509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.
    Baker LD; Cross DJ; Minoshima S; Belongia D; Watson GS; Craft S
    Arch Neurol; 2011 Jan; 68(1):51-7. PubMed ID: 20837822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of regional gray matter atrophy, white matter alteration, and glucose metabolism as a predictor of the conversion to Alzheimer's disease in mild cognitive impairment.
    Sohn BK; Yi D; Seo EH; Choe YM; Kim JW; Kim SG; Choi HJ; Byun MS; Jhoo JH; Woo JI; Lee DY
    J Korean Med Sci; 2015 Jun; 30(6):779-87. PubMed ID: 26028932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter lesions impair frontal lobe function regardless of their location.
    Tullberg M; Fletcher E; DeCarli C; Mungas D; Reed BR; Harvey DJ; Weiner MW; Chui HC; Jagust WJ
    Neurology; 2004 Jul; 63(2):246-53. PubMed ID: 15277616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal cortical functional activity in patients with ischemic white matter lesions: A resting-state functional magnetic resonance imaging study.
    Ding X; Ding J; Hua B; Xiong X; Xiao L; Peng F; Chen L; Pan X; Wang Q
    Neurosci Lett; 2017 Mar; 644():10-17. PubMed ID: 28189742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study.
    Del Sole A; Clerici F; Chiti A; Lecchi M; Mariani C; Maggiore L; Mosconi L; Lucignani G
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1357-66. PubMed ID: 18418593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter microstructural damage in small vessel disease is associated with Montreal cognitive assessment but not with mini mental state examination performances: vascular mild cognitive impairment Tuscany study.
    Pasi M; Salvadori E; Poggesi A; Ciolli L; Del Bene A; Marini S; Nannucci S; Pescini F; Valenti R; Ginestroni A; Toschi N; Diciotti S; Mascalchi M; Inzitari D; Pantoni L;
    Stroke; 2015 Jan; 46(1):262-4. PubMed ID: 25395414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship Between the Japanese Version of the Montreal Cognitive Assessment and PET Imaging in Subjects with Mild Cognitive Impairment.
    Eguchi A; Kimura N; Aso Y; Yabuuchi K; Ishibashi M; Hori D; Sasaki Y; Nakamichi A; Uesugi S; Jikumaru M; Sumi K; Shimomura T; Matsubara E
    Curr Alzheimer Res; 2019; 16(9):852-860. PubMed ID: 31385770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings.
    Petrie EC; Cross DJ; Galasko D; Schellenberg GD; Raskind MA; Peskind ER; Minoshima S
    Arch Neurol; 2009 May; 66(5):632-7. PubMed ID: 19433663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates.
    Chou KL; Lenhart A; Koeppe RA; Bohnen NI
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1076-80. PubMed ID: 25085750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults.
    DeCarli C; Murphy DG; Tranh M; Grady CL; Haxby JV; Gillette JA; Salerno JA; Gonzales-Aviles A; Horwitz B; Rapoport SI
    Neurology; 1995 Nov; 45(11):2077-84. PubMed ID: 7501162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.